• Info
  • Significant Ownership

Significant Ownership of INTEGRATED CORE STRATEGIES (US) LLC

Signature - Title
/s/ Gil Raviv - Gil Raviv, Global General Counsel
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by INTEGRATED CORE STRATEGIES (US) LLC.

Notify me when INTEGRATED CORE STRATEGIES (US) LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of INTEGRATED CORE STRATEGIES (US) LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Infinite Eagle Acquisition Corp. Class A Ordinary Shares, par value $0.0001 per share 9.8% 2,970,000 Millennium Management LLC 16 Jan 2026
SRZN Surrozen, Inc. Common Stock, par value $0.0001 per share 8.5% $15,649,459 +$3,477,006 726,193 +29% Millennium Management LLC 31 Dec 2025
BTAI BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share 8.4% $3,762,144 +$1,654,635 1,835,192 +79% Millennium Management LLC 31 Dec 2025
MYGN Myriad Genetics, Inc. Common Stock, par value $0.01 per share 7.2% $41,205,972 +$12,003,761 6,700,158 +41% Millennium Management LLC 31 Dec 2025
TENX Tenax Therapeutics, Inc. Common Stock, par value $0.0001 per share 6.9% $1,882,272 +$480,576 313,712 +34% Integrated Core Strategies (US) LLC 30 Sep 2025
CYRX Cryoport, Inc. Common Stock, par value $0.001 per share 6.5% $31,150,099 +$6,548,016 3,244,802 +27% Millennium Management LLC 31 Dec 2025
LIVN LivaNova PLC Ordinary Shares, par value GBP 1.00 per share 6.4% $225,141,379 +$33,212,612 3,484,082 +17% Millennium Management LLC 31 Dec 2025
Harvard Ave Acquisition Corporation Class A Ordinary Shares, par value $0.0001 per share 6.4% 950,000 Millennium Management LLC 23 Oct 2025
Helix Acquisition Corp. III Class A Ordinary Shares, par value $0.0001 per share 6.2% 1,098,535 Millennium Management LLC 23 Jan 2026
LYFT Lyft, Inc. Class A Common Stock, par value $0.00001 per share 6.1% $441,831,536 24,276,458 Millennium Management LLC 11 Feb 2026
VYGR Voyager Therapeutics, Inc. Common Stock, par value $0.001 per share 6.1% $13,394,000 3,407,969 Millennium Management LLC 16 Jan 2026
BEBE TGE Value Creative Solutions Corp Class A Ordinary Shares, par value $0.0001 per share 6% 900,000 Millennium Management LLC 19 Dec 2025
ZEPP Zepp Health Corporation Class A Ordinary Shares, par value $0.0001 per share 5.8% $303,726,978 6,634,592 Millennium Management LLC 05 Nov 2025
BRZE Braze, Inc. Class A Common Stock, par value $0.0001 per share 5.6% $215,915,847 6,296,685 Millennium Management LLC 27 Jan 2026
KRUS Kura Sushi USA, Inc. Class A Common Stock, par value $0.001 per share 5.6% $32,639,163 623,718 Integrated Core Strategies (US) LLC 02 Feb 2026
KIDS OrthoPediatrics Corp. Common Stock, par value $0.00025 per share 5.5% $25,768,856 1,390,656 Millennium Management LLC 29 Oct 2025
KPTI Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share 5.5% $7,252,280 1,008,662 Millennium Management LLC 04 Feb 2026
UNCY Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share 5.5% $6,555,209 1,172,667 Integrated Core Strategies (US) LLC 16 Jan 2026
SLVM Sylvamo Corporation Common Stock, par value $1.00 per share 5.4% $88,221,844 2,148,608 Millennium Management LLC 18 Nov 2025
ARDX Ardelyx, Inc. Common Stock, par value $0.0001 per share 5.4% $76,499,983 13,121,781 Millennium Management LLC 05 Jan 2026
AMN AMN Healthcare Services, Inc. Common Stock, par value $0.01 per share 5.2% $31,614,024 -$6,935,314 2,005,966 -18% Millennium Management LLC 31 Dec 2025
IBIO iBio, Inc. Common Stock, par value $0.001 per share 5.2% $2,381,068 1,235,827 Millennium Management LLC 15 Jan 2026
SLRN ACELYRIN, INC. Common Stock, par value $0.00001 per share 4.7% $11,550,285 4,714,402 Integrated Core Strategies (US) LLC 31 Dec 2024
HLXB Helix Acquisition Corp. II Class A Ordinary Shares, par value $0.0001 per share 4.7% $9,555,723 897,251 Millennium Management LLC 30 Jun 2025
QNRX Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share 4.6% $36,005,681 +$9,858,888 2,618,595 +38% Integrated Core Strategies (US) LLC 31 Dec 2025
ADPT Adaptive Biotechnologies Corporation Common Stock, par value $0.0001 per share 4.3% $49,711,809 6,292,634 Millennium Management LLC 31 Dec 2024
PYXS Pyxis Oncology, Inc. Common Stock, par value $0.001 per share 4% $2,587,602 -$698,942 2,488,079 -21% Millennium Management LLC 31 Mar 2025
CPIX Cumberland Pharmaceuticals Inc. Common Stock, no par value 4% $1,618,467 -$571,171 598,634 -26% Integrated Core Strategies (US) LLC 30 Sep 2025
FHN First Horizon Corporation Common Stock, par value $0.625 per share 3.8% $449,728,427 -$157,467,779 18,817,089 -26% Millennium Management LLC 31 Dec 2025
ACCD Accolade, Inc. Common Stock, par value $0.0001 per share 3.8% $21,697,844 3,090,861 Millennium Management LLC 31 Dec 2024
SEE Sealed Air Corporation Common Stock, par value $0.10 per share 3.7% $181,370,784 -$72,119,443 5,397,940 -28% Millennium Management LLC 11 Nov 2025
CMA Comerica Incorporated Common Stock, par value $5 per share 3.6% $315,762,635 -$279,206,324 4,608,328 -47% Millennium Management LLC 07 Oct 2025
AMG Affiliated Managers Group, Inc. Common Stock, par value $0.01 per share 3.6% $242,510,253 -$116,590,124 1,017,113 -32% Millennium Management LLC 30 Sep 2025
LXEO Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share 3.2% $15,362,583 -$3,470,396 2,313,642 -18% Millennium Management LLC 30 Sep 2025
GVA Granite Construction Incorporated Common Stock, par value $0.01 per share 3% $102,538,079 1,283,009 Millennium Management LLC 31 Mar 2025
NKTR Nektar Therapeutics Common Stock, par value $0.0001 per share 3% $32,489,559 -$20,590,346 570,994 -39% Millennium Management LLC 30 Sep 2025
CMPS COMPASS Pathways plc American Depositary Shares, each representing one ordinary share, par value of GBP 0.008 per share 3% $10,456,174 -$2,412,525 2,773,521 -19% Millennium Management LLC 31 Mar 2025
UTZ Utz Brands, Inc. Class A Common Stock, par value $0.0001 per share 2.9% $26,388,721 -$20,572,134 2,542,217 -44% Millennium Management LLC 31 Dec 2025
NEO NeoGenomics, Inc. Common Stock, par value $0.001 per share 2.8% $26,073,366 -$24,761,251 3,566,808 -49% Millennium Management LLC 30 Jun 2025
RVPH Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share 2.8% $912,148 3,257,670 Millennium Management LLC 31 Dec 2025
UWMC UWM Holdings Corporation Class A Common Stock, par value $0.0001 per share 2.5% $21,192,426 -$32,680,198 4,974,748 -61% Millennium Management LLC 30 Jun 2025
ENTA Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share 2.3% $10,572,650 -$7,381,243 670,428 -41% Millennium Management LLC 31 Dec 2025
ANGO AngioDynamics, Inc. Common Stock, par value $0.01 per share 2% $10,818,316 -$16,734,886 842,548 -61% Millennium Management LLC 31 Dec 2025
ABEO Abeona Therapeutics Inc. Common Stock, par value $0.01 per share 1.7% $4,292,820 809,966 Millennium Management LLC 31 Mar 2025
MIST Milestone Pharmaceuticals Inc. Common Shares, no par value 0.6% $396,161 322,082 Integrated Core Strategies (US) LLC 31 Mar 2025
ATXS Astria Therapeutics, Inc. Common Stock, par value $0.001 per share 0.4% $1,616,895 -$19,770,311 222,101 -92% Millennium Management LLC 14 Oct 2025
ANIP ANI Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 0.3% $5,976,442 -$96,309,614 65,245 -94% Millennium Management LLC 30 Sep 2025
GLNG Golar LNG Limited Common Shares, par value $1.00 per share 0% $0 -$220,684,058 0 -100% Integrated Core Strategies (US) LLC 31 Mar 2025
PHIN PHINIA Inc. Common Stock, par value $0.01 per share 0% $0 0 Integrated Core Strategies (US) LLC 31 Mar 2025

Schedules 13D/G Reported by INTEGRATED CORE STRATEGIES (US) LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.